Open AccessEfficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID
Author(s) -
Gilles Boschetti,
Maria Nachury,
David Laharie,
Xavier Roblin,
Cyrielle Gilletta,
Alexandre Aubourg,
Arnaud Bourreille,
Camille Zallot,
Xavier Hébuterne,
A. Buisson,
J-C. Grimaud,
Yoram Bouhnik,
Matthieu Allez,
Romain Altwegg,
Stéphanie Viennot,
Lucine Vuitton,
Franck Carbonnel,
Stéphane Paul,
Kristell Desseaux,
Jérôme Lambert,
Laurent Peyrin Biroulet
Publication year - 2022
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000001842
Subject(s) - medicine , discontinuation , infliximab , prospective cohort study , crohn's disease , cohort , observational study , adverse effect , cohort study , clinical endpoint , surgery , randomized controlled trial , disease